Search Results - "Guerret, M."

Refine Results
  1. 1

    Routine determination of morphine, morphine 3-β-d-glucuronide and morphine 6-β-d-glucuronide in human serum by liquid chromatography coupled to electrospray mass spectrometry by Blanchet, M, Bru, G, Guerret, M, Bromet-Petit, M, Bromet, N

    Published in Journal of Chromatography A (27-08-1999)
    “…A robust liquid chromatographic mass spectrometric method capable of quantifying morphine, morphine 3-β-d-glucuronide and morphine 6-β-d-glucuronide down to…”
    Get full text
    Journal Article Conference Proceeding
  2. 2

    Effect of Meal Timing Not Critical for the Pharmacokinetics of Tegaserod (HTF 919) by Zhou, Honghui, Khalilieh, Sauzanne, Lau, Henry, Guerret, Madeleine, Osborne, Stuart, Alladina, Latifa, Laurent, Aziz L., McLeod, James F.

    Published in Journal of clinical pharmacology (01-09-1999)
    “…This study assessed the pharmacokinetic profiles of administering tegaserod (HTF 919) at different time intervals with respect to a meal. It was a randomized,…”
    Get full text
    Journal Article
  3. 3

    Single- and Multiple-Dose Pharmacokinetics of Sdz Htf 919 In Healthy Subjects by Appel‐Dingemanse, S., Guerret, M., Hirschberg, Y., McLeod, J.

    Published in Clinical pharmacology and therapeutics (01-02-1999)
    “…Clinical Pharmacology & Therapeutics (1999) 65, 128–128; doi:…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Cyclosporine and Nonsteroidal Antiinflammatory Drugs: Exploring Potential Drug Interactions and Their Implications for the Treatment of Rheumatoid Arthritis by Kovarik, J. M., Mueller, E. A., Gerbeau, C., Tarral, A., Francheteau, P., Guerret, M.

    Published in Journal of clinical pharmacology (01-04-1997)
    “…A series of clinical pharmacology studies was performed to screen for possible pharmacokinetic/dynamic contributions to drug interactions reported in…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Effect of nicardipine in elderly hypertensive patients by Forette, F., Bellet, M., Henry, JF, Hervy, MP, Poyard‐Salmeron, C., Bouchacourt, P., Guerret, M.

    Published in British journal of clinical pharmacology (01-01-1985)
    “…The purpose of this study was to test tolerance and the antihypertensive effect of nicardipine, a new calcium antagonist, in 31 elderly patients aged 57‐95…”
    Get full text
    Journal Article
  8. 8

    Simultaneous study of the pharmacokinetics of intravenous and oral nicardipine using a stable isotope by GUERRET, M, CHEYMOL, G, HUBERT, M, JULIEN-LAROSE, C, LAVENE, D

    Published in European journal of clinical pharmacology (01-01-1989)
    “…The systemic elimination of nicardipine has been studied by an initial oral administration of nicardipine followed 1.25 h later by intravenous injection of the…”
    Get full text
    Journal Article
  9. 9

    Role of isoflurane on hemodynamic properties and disposition of nicardipine by Chelly, J E, Hysing, E S, Abernethy, D R, Doursout, M F, Hartley, C J, Guerret, M, Merin, R G

    “…Nicardipine properties (30 micrograms/kg i.v.) were studied in a group of eight dogs awake and anesthetized with isoflurane 1.6% end-tidal. Awake, nicardipine…”
    Get more information
    Journal Article
  10. 10
  11. 11

    Influence of digestive secretions and food on intestinal absorption of nicardipine by DELCHIER, J. C, GUERRET, M, VIDON, N, DUBRAY, C, LAVENE, D

    Published in European journal of clinical pharmacology (01-01-1988)
    “…The role of digestive absorption in the pharmacokinetics of nicardipine has been studied by the perfusion technique. Nicardipine (40 mg) was perfused in six…”
    Get full text
    Journal Article
  12. 12

    Kinetics and hemodynamic effects of intravenous nicardipine modified by previous propranolol oral treatment by ROCHA, P, GUERRET, M, DAVID, D, MARCHAND, X, KAHN, J. C

    Published in Cardiovascular drugs and therapy (01-12-1990)
    “…Intravenous nicardipine, 5 mg, was administered in two comparable groups of eight patients with chronic coronary artery disease but no clinical signs of heart…”
    Get full text
    Journal Article
  13. 13

    Determination of pindolol in biological fluids by electron-capture GLC by Guerret, M, Lavene, D, Kiechel, J R

    Published in Journal of pharmaceutical sciences (01-10-1980)
    “…An electron-capture GLC method was developed for measuring pindolol in human plasma and urine. The unchanged drug was extracted with benzene from alkalinized…”
    Get more information
    Journal Article
  14. 14

    Longitudinal assessment of a P‐glycoprotein–mediated drug interaction of valspodar on digoxin by Kovarik, John M., Rigaudy, Laurence, Guerret, Madeleine, Gerbeau, Christophe, Rost, Karl‐Ludwig

    Published in Clinical pharmacology and therapeutics (01-10-1999)
    “…Objectives Valspodar is a P‐glycoprotein modulator currently under development as a multidrug resistance reversal agent in clinical oncology. A multiple‐dose…”
    Get full text
    Journal Article
  15. 15

    Determination of 3-hydroxy-guanfacine in biological fluids by electron-capture gas-liquid chromatography by Guerret, M, Julien-Larose, C, Kiechel, J R, Lavène, D

    Published in Journal of chromatography (10-12-1982)
    “…An electron-capture gas-liquid chromatographic method was developed for measuring 3-hydroxy-guanfacine, the main metabolite of guanfacine in human plasma and…”
    Get more information
    Journal Article
  16. 16

    Determination of guanfacine in biological fluids by electron-capture GLC by Guerret, M, Lavene, D, Longchampt, J, Kiger, J L

    Published in Journal of pharmaceutical sciences (01-02-1979)
    “…A quantitative electron-capture GLC method with good sensitivity is described for the determination of guanfacine in human plasma and urine. By condensing its…”
    Get more information
    Journal Article
  17. 17

    Estimation of the absolute oral bioavailability of pindolol by two analytical methods by GUERRET, M, CHEYMOL, G, AUBRY, J. P, CHEYMOL, A, LAVENE, D, KIECHEL, J. R

    “…The absolute oral bioavailability of pindolol has been estimated by two analytical methods, fluorimetry and GLC-ECD. The study was carried out in six healthy…”
    Get full text
    Journal Article
  18. 18

    Pharmacokinetic aspects of guanfacine withdrawal syndrome in a hypertensive patient with chronic renal failure by KIECHEL, J. R, LAVENE, D, GUERRET, M, COMOY, E, GODIN, M, FILLASTRE, J. P

    Published in European journal of clinical pharmacology (01-01-1983)
    “…The unusual observation of a withdrawal syndrome due to guanfacine in a hypertensive patient with chronic renal failure led to a study of the kinetics of the…”
    Get full text
    Journal Article
  19. 19

    Quantification of ketotifen and its metabolites in human plasma by gas chromatography mass spectrometry by Julien-Larose, C, Guerret, M, Lavene, D, Kiechel, J R

    Published in Biomedical mass spectrometry (01-03-1983)
    “…Gas chromatography mass spectrometry with selected ion monitoring has been used to develop a method for the quantification of ketotifen and its demethylated,…”
    Get more information
    Journal Article
  20. 20

    Evaluation of Effects of Terbinafine on Single Oral Dose Pharmacokinetics and Anticoagulant Actions of Warfarin in Healthy Volunteers by Guerret, Madeleine, Francheteau, Patrice, Hubert, Martine

    Published in Pharmacotherapy (01-07-1997)
    “…Study Objective. To evaluate the potential effects of oral terbinafine, a new synthetic antifungal agent of the allylamine class, on the pharmacokinetics and…”
    Get full text
    Journal Article